Stock Market News
Bristol Myers to buy RayzeBio for about $4.1 billion
2023.12.26 07:44
© Reuters. FILE PHOTO: A sign stands outside a Bristol Myers Squibb facility in Cambridge, Massachusetts, U.S., May 20, 2021. REUTERS/Brian Snyder/File Photo
(Reuters) – Bristol Myers (NYSE:) Squibb said on Tuesday it will acquire radiopharmaceutical firm RayzeBio for about $4.1 billion.
Bristol said it will pay $62.50 for each share of RayzeBio in cash, representing a premium of 104% to stock’s last close.
RayzeBio shares were halted ahead of the deal announcement.
